Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
CD40-CD40L interactions in atherosclerosis
Esther Lutgens
,
Mat J. A. P. Daemen
Other Departments
Affiliatie UvA
Research output
:
Contribution to journal
›
Review article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CD40-CD40L interactions in atherosclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
CD40 Ligand (CD40L)
100%
Plaque Rupture
40%
Macrophages
20%
Plaque
20%
Atherosclerotic Lesions
20%
Smooth muscle Cells
20%
T Cells
20%
Atherosclerotic Plaque
20%
Collagen
20%
CD40
20%
Novel Therapeutics
20%
Plaque Phenotype
20%
Plaque Destabilization
20%
Evidence Support
20%
Pharmacological Inhibitors
20%
Acute Complications
20%
Ruptured Plaque
20%
ApoE KO Mice
20%
Atherosclerotic Plaque Stability
20%
CD40L Deficiency
20%
Medicine and Dentistry
Atherosclerosis
100%
CD40 Ligand
100%
T Lymphocyte
16%
Macrophage
16%
Smooth Muscle Cell
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
CD40 Ligand
100%
Apolipoprotein E Knockout Mouse
16%